2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- has been researched along with lobeline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eshleman, AJ; Gonzalez, M; Janowsky, A; Johnson, RA; Kryatova, O; Meltzer, PC; Nelson, J; Provencher, BA; Shi, X; Tian, J | 1 |
| Crooks, PA; Deaciuc, AG; Dwoskin, LP; Horton, DB; Zheng, G | 1 |
2 other study(ies) available for 2h-benzo(a)quinolizin-2-ol, 2-ethyl-1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy- and lobeline
| Article | Year |
|---|---|
Synthesis and Discovery of Arylpiperidinylquinazolines: New Inhibitors of the Vesicular Monoamine Transporter.
Topics: Animals; Chemistry Techniques, Synthetic; Drug Design; HEK293 Cells; Humans; Ligands; Mice; Quinazolines; Vesicular Monoamine Transport Proteins | 2018 |
Des-keto lobeline analogs with increased potency and selectivity at dopamine and serotonin transporters.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Dopamine Plasma Membrane Transport Proteins; Humans; Lobeline; Protein Binding; Receptors, Nicotinic; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism; Structure-Activity Relationship; Vesicular Monoamine Transport Proteins | 2006 |